期刊文献+

胸骨穿刺对髂骨增生低下骨髓增生异常综合征诊断意义探讨 被引量:4

Discussion on the significance of sternal puncture in diagnosis of myelodysplastic syndrome patients with hypoplasia through iliac puncture
原文传递
导出
摘要 目的:探讨胸骨骨穿对于骨髓增生异常综合征(MDS)的诊断意义。方法:分析我院31例经胸骨骨穿诊断的MDS,对同期的髂骨和胸骨骨髓像进行对比研究。结果:31例经胸骨诊断为MDS的患者髂骨穿刺及髂骨活检表现为增生低下,按WHO分型均为MDS-RCMD;31例髂骨骨髓增生低下患者粒系、红系少见病态造血,粒系仅6.5%(2例)出现巨幼样变,12.9%(4例)患者出现核浆发育失衡,红系仅6.5%(2例)患者出现巨幼样改变,巨核细胞少见,仅3.2%(1例)患者见到4个巨核细胞,未见到病态巨核细胞;相反,同期的胸骨骨髓均表现为增生活跃或明显活跃,三系病态造血明显,在粒系病态造血表现中54.8%(17例)出现双核粒,71.0%(22例)出现了巨幼样粒细胞,93.5%(29例)出现了核浆发育失衡粒细胞,22.6%(7例)出现了假性派胡细胞;红系病态造血表现中,35.5%(11例)患者出现三核红细胞,77.4%(24例)患者出现巨幼样红细胞;87.1%(27例)患者巨核系统出现病态造血,其中小巨核、单圆核、双圆核、三圆核巨核出现的比例分别为19.4%(6例)、77.4%(24例)、35.5%(11例)、35.5%(11例)。结论:部分MDS患者表现为髂骨增生低下,髂骨穿刺发现病态造血的概率低,胸骨穿刺能有效地发现具有重要意义的病态造血表现,为诊断提供明确的依据,是诊断此类MDS的重要方法。 Objective:To explore the significance of sternal puncture in the diagnosis of MDS. Method:We analyzed 31 MDS cases which were all diagnosed by sternal puncture and compared the morphology of bone marrow cells obtained from ilium and sternum at the same time. Result:These MDS patients were all diagnosed hypoplastic through bone marrow aspiration and bone marrow biopsy at ilium,and finally diagnosed as RCMD according to WHO classification after sternal puncture;there was little dysplasia in granulopoiesis and erythropoiesis anmong these 31 cases with low hyperplasia through iliac puncture bone marrow aspirates.Only 6.5%(2 cases) patients had Megaloblastoid changes and 12.9%(4 cases)patients had nuclear-cytoplasm asynchrony in granulopoiesis;Only 6.5%(2 cases) patients had Megaloblastoid changes in erythropoiesis;Only 3.2%(1 case) patients had four megakaryocytes,other patients did not have megakaryocytes and the four megakaryocytes were normal;On the other hand,in the same period,all patients'bone marrows were active or more active though sternal puncture,and the dysplasia was obvious.The number and incidence of multinuclearity,megaloblastoid,nuclear-cytoplasm asynchrony in granulopoiesis was 17(54.8%),22(71%),29(93.5%);In erythropoiesis,the number and incidence of multinuclearity,megaloblastoid was 11(35.5%),24(77.4%);In megakaryocytic series,87.1%(27 cases) patients had dysplasia.The number and incidence of micromegakaryocytes,round nucleus,binucleated megakaryocyte,megakaryocyte with round separated nuclei was 6 cases(19.4%),24 cases(77.4%),11 cases(35.5%),11 cases(35.5%). Conclusion:Some MDS patients show hypoplastic through iliac puncture bone marrow aspirates,the chance of fouding dysplasia is very low.However we can effectively found significant pathological hematopoietic performance through sternal puncture,and the significant dysplasia is very important for the diagnosis of MDS.As a result,sternal puncture is a major method for diagnosis of such MDS.
出处 《临床血液学杂志》 CAS 2013年第2期162-165,共4页 Journal of Clinical Hematology
基金 国家自然科学基金资助项目(No:31973812 31973903)
关键词 骨髓增生异常综合征 髂骨穿刺 胸骨穿刺 病态造血 myelodysplastic syndrome iliac puncture sternal puncture dysplasia
  • 相关文献

参考文献7

  • 1BRUNNING R D, A O, GERMING U,et al. Myelo-dysplastic syndromes/Neoplasms, overview [ M ]//SWERDLOW S H.CAMPO E, HARRIS N L,et al.WHO classification of tumours of haematopoietic andlymphoid tissues. Lyon: I ARC, 2008 : 88 -93.
  • 2肖志坚.循证医学指导下的血液病规范化诊治[J].中国实用内科杂志,2007,27(14):1091-1094. 被引量:18
  • 3肖志坚.骨髓增生异常综合征的诊断与分型[J].内科急危重症杂志,2010,16(4):169-171. 被引量:13
  • 4MARISAVLJEVIC DXEMERIKIC V,ROLOVIC Z,et al. Hypocellular myelodysplastic syndromes : clinicaland biological significance [J]. Med Oncol,2005,22 :169-175.
  • 5刘新月.细胞发育异常——MDS诊断关键之所在[J].临床血液学杂志,2011,24(6):642-644. 被引量:4
  • 6SCHECTER J,GALIU N’RAZA A. MDS: Refiningexisting therapy through improved biologic insights[J]. Blood Rev,2012,26 :73 -80.
  • 7PASSWEG J R,GIAGOUNIDIS A A,SIMCOCK M,et al. Immunosuppressive therapy for patients withmyelodysplastic syndrome: A prospective randomizedmulticenter phase E trial compareing antithymocyteglobulin plus cyclosporine with best supportive care-sakk33/99[J]. J Clin Oncol,2011,29 :313-319.

二级参考文献26

  • 1肖志坚.骨髓增生异常综合征:现况与问题[J].白血病.淋巴瘤,2005,14(4):193-196. 被引量:31
  • 2肖志坚,郝玉书.骨髓增生异常综合征的治疗选择[J].中华内科杂志,2007,46(4):265-267. 被引量:7
  • 3Acquaviva C, Gelsi-Boyer V, Birnbaum D. Myelodysplastic syndromes: lost between two states? Leukemia, 2010, 24.1.
  • 4Brunning RD, AO, Germing U, et al. Myelodysplastic syndromes/Neoplasms, overview. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon:IARC,2008, p. 88-93.
  • 5Komrokji RS, Zhang L, Bennett JM. Myelodysplastic syndromes classification and risk stratification. Hematol Oncol Clin N Am,2010,24:443.
  • 6Mufti GJ, Bennett JM, Goasguen J, et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica, 2008, 93: 1712.
  • 7van de Loosdrecht AA, Alhan C, Bene MC, et al. Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cyto metry in myelodysplastic syndromes. Haematologica, 2009,94:1124.
  • 8Peter Valent, Hans-Peter Horny, John M, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res, 2007,31 : 727.
  • 9BENNETT J M, CATOVSKY D, DANIEL M T, et al. Proposals for the classification of the myelodysplastic syndromes[J].Br J Haematol ,1982,51:189 --199.
  • 10VARDIMAN J W, HARRIS N I., BRUNNING R D The World Health Organization (WHO) classifica tion of the myeloid neoplasms[J]. Blood, 2002,100 :2292 -2302.

共引文献31

同被引文献47

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部